To 'First, Do No Harm,' You Must Start With Good Evidence.
The intrepid young oncologist's criticism of cancer screening and surrogate endpoints has stirred up controversy. Prasad thinks that providers should offer medical therapies that do more good than harm. "I mean things that matter to people, which is living longer, living better."